Shanghai RAAS Blood Products (002252.SZ) Subsidiary Obtains Human Fibrinogen Drug Registration Certificate

Shanghai RAAS (002252.SZ) announced that its wholly-owned subsidiary, Nanyue Biopharmaceutical Co., Ltd. ("Nanyue Biopharma"), recently received the Human Fibrinogen Drug Registration Certificate issued by the National Medical Products Administration. Human fibrinogen is prepared from healthy human plasma through separation, purification, viral removal and inactivation, and freeze-drying. This product from Nanyue Biopharma is indicated for congenital fibrinogen deficiency or afibrinogenemia.